Lemonade Inc (LMND)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Lemonade Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 3 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 48.30 $ — 20% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
5 of 10 Solid growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 42.2% passed
- More than 10% revenue growth is expected for the coming year 33.8% passed
- Share count grows by less than 3% a year 3.4% failed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 36.6% failed
- Gross margin at 40% or higher and without meaningful erosion 40.3% passed
- Goodwill from acquisitions does not grow faster than revenue 1.0% passed
- Net debt below twice EBITDA 926 m net cash passed
- Operating cash flow covers the profits of the last three years 458 m failed
- Return on capital at 15% or higher, or up versus two years ago -22.5% failed
- Insiders hold at least 10% or are net buyers 8.7% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Analysts & Price Target
The price target sits 26.7% above the current price.
- Consensus
- Buy
- Analyst Ratings
- 9
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | -1.88 | -1.97 – -1.80 | 1,214 | 22.6% | 10 |
| 12/31/2027 | -1.04 | -1.81 – -0.61 | 1,638 | 52.2% | 12 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.42 | – | 149 | 28.80 | -20.20 | 14 | 11 |
| 2025: Q1 | -0.86 | – | 151 | 27.00 | -41.30 | -47 | -50 |
| 2025: Q2 | -0.60 | – | 164 | 34.50 | -26.80 | 6 | 3 |
| 2025: Q3 | -0.51 | – | 195 | 42.40 | -19.30 | 5 | 3 |
| 2025: Q4 | -0.30 | – | 228 | 53.30 | -9.50 | 21 | 18 |
| 2026: Q1 | -0.47 | – | 234 | 55.00 | -15.30 | -1 | -4 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2017 | 2 | -26 | -28 | -2.58 | -19 | 32 | 41 |
| 2018 | 23 | -53 | -53 | -1.21 | -41 | -79 | 154 |
| 2019 | 67 | -108 | -109 | -2.49 | -78 | -183 | 414 |
| 2020 | 94 | -121 | -122 | -2.21 | -92 | 541 | 829 |
| 2021 | 128 | -234 | -241 | -3.94 | -145 | 988 | 1,511 |
| 2022 | 257 | -295 | -298 | -4.59 | -163 | 867 | 1,691 |
| 2023 | 430 | -230 | -237 | -3.40 | -119 | 709 | 1,299 |
| 2024 | 527 | -204 | -202 | -2.85 | -11 | 593 | 1,849 |
| 2025 | 738 | -161 | -166 | -2.30 | -17 | 534 | 1,926 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Lemonade, Inc. bietet verschiedene Versicherungsprodukte in den USA, Europa, Louisiana und dem Vereinigten Königreich an.
| Employees | 1,282 |
|---|---|
| Headquarters | New York, NY |
| Address | 5 Crosby Street, 10013 New York, United States |
| Phone | 844 733 8666 |
| Website | lemonade.com |
| IPO Date | 2. Jul 2020 |
| ISIN | US52567D1072 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Daniel Asher Schreiber | CO-Founder, Chairman & CEO | 1971 |
| Shai Wininger Gavish | Co-Founder, President & Director | 1974 |
| Maya Prosor | Co-Founder & Chief Business Officer | 1985 |
| Timothy E. Bixby | CFO, Principal Accounting Officer & Treasurer | 1965 |
| Adina Eckstein | Chief Operating Officer | 1986 |
| John Sheldon Peters | Chief Insurance Officer | 1972 |
| Dennis Monaghan | General Counsel & Secretary | – |
| Sean Parker Burgess | Chief Claims Officer | – |
| Michal Langer | Chief Product Officer | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 27. Jul 2026 | Peters John Sheldon | Chief Insurance Officer | Other | 10,000 | 0.00 | – |
| 7. Jul 2026 | Bixby Timothy E | Chief Financial Officer | Sell | 73,000 | 79.18 | 5,780,140 |
| 6. Jul 2026 | Peters John Sheldon | Chief Insurance Officer | Sell | 3,444 | 79.00 | 272,076 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.